Dr. Dillon Daniel Clarey, MD Dermatology Medicare: Medicare Enrolled Practice Location: 4508 38th St Ste 210, Columbus, NE 68601 Phone: 402-562-4871 |
News Archive
After visiting Ghana on a recent tour to examine poverty reduction strategies and progress on the Millennium Development Goals (MDGs), Jeffrey Sachs, director of the Earth Institute at Columbia University and "one of the world's most prominent development economists, says Ghana is proving to be one of the strongest performers on the [MDGs] in Africa and unlike some of its African counterparts is likely to fulfill them by the 2015 deadline," the Christian Science Monitor reports.
Cellectar, Inc., a privately held radiopharmaceutical company that designs and develops products to detect, treat and monitor human cancers, today announced that enrollment for its Phase I dosimetry trial for its lead drug candidate, (131)I-CLR1404 has been completed. Results of this trial will be used to set the starting dose in a follow-on Phase I dose escalation study planned for later this year. Institutions that participated in the trial include City of Hope, Duke University Medical Center, Georgetown University/Lombardi Cancer Center, and Johns Hopkins Hospital.
This World Cancer Day, we provide information and advice for those who want to reduce their risk of cancer, are caring for someone with cancer or simply want to learn more.
Local United Auto Workers leaders representing Ford Motor employees on Monday by voice vote unanimously approved a tentative four-year contract agreement that follows the pattern set by General Motors and Chrysler Group and includes the creation of a voluntary employees' beneficiary association, the AP/Philadelphia Inquirer reports (Krisher/Durbin, AP/Philadelphia Inquirer, 11/6).
› Verified 1 days ago